Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.29%
#2 Ocean Protocol Ocean Protocol +18.64%
#3 KUB Coin KUB Coin +12.98%
#4 Audiera Audiera +10.79%
#5 Perle Perle +10.63%
#6 Wiki Cat Wiki Cat +9.96%
#7 Geodnet Geodnet +9.46%
#8 Arowana Arowana +9.35%
#9 OpenEden OpenEden +8.17%
#10 DexNet DexNet +7.78%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
設定
言語
日本
通貨
USD
テーマ
Al-Razi Medical Co. Al-Razi Medical Co.

Al-Razi Medical Co.

9572
株式のランク #32121
Established in 1986 and based in Dammam, Saudi Arabia, Al-Razi Medical Company... Established in 1986 and based in Dammam, Saudi Arabia, Al-Razi Medical Company functions as a principal distributor of a broad range of medical equipment throughout the Kingdom. Their extensive product catalog encompasses essentials like hospital beds, steam and suction devices, inhalation apparatus, various masks (including oxygen masks), needles, water bladders, bandages, gloves, and ear piercing provisions. The company caters to a diverse clientele within the healthcare sector, serving hospitals, clinics, medical centers, other medical enterprises, and pharmacies.
株価
$7.26
最終同期: 2026-08-17
時価総額
$11.03M
変化（1日）
-0.29%
変化（1年）
-32.12%
国
SA
取引 Al-Razi Medical Co. (9572)

カテゴリー

Healthcare
Al-Razi Medical Co.（9572）の収益
Aug 2026 時点の収益 TTM: 0
Al-Razi Medical Co. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Al-Razi Medical Co. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US